FluxBio uses synthetic biology and precision fermentation to engineer microorganisms that produce recombinant proteins for industrial applications. By designing genetic constructs and optimizing fermentation processes, they create sustainable, cost‑effective protein ingredients that replace animal‑derived or synthetic components in sectors such as aquaculture, sports nutrition, cosmetics, women's health, and infant nutrition.
Funding
Funding not disclosed
Founders
Product
Problem
Industries such as aquaculture, sports nutrition, cosmetics, and infant formula rely heavily on animal‑derived or chemically synthesized ingredients, which can be costly, environmentally damaging, and subject to supply constraints. This creates a need for sustainable, scalable alternatives that meet performance and safety standards.
Solution
FluxBioFactories applies synthetic biology and precision fermentation to engineer microorganisms that act as cellular factories for recombinant proteins. By designing genetic constructs and optimizing host chassis, the company produces target proteins in bioreactors, converting simple nutrients into high‑value bioproducts. The resulting proteins replace animal‑based or synthetic ingredients, offering comparable functionality with lower environmental impact and competitive cost. Their R&D workflow validates market hypotheses, pricing, and scalability through rapid pilot iterations, ensuring that each product meets commercial viability criteria before scale‑up. This approach enables the delivery of sustainable, performance‑driven ingredients across multiple sectors.
Target Audience
Primary customers include manufacturers in aquaculture, sports nutrition, cosmetics, women's health, and infant nutrition seeking sustainable protein ingredients for their formulations.
Features
- Genetic engineering of microbial strains to express specific recombinant proteins for industrial use
- Precision fermentation processes that convert basic nutrients into target proteins at scale
- Integrated cost and scalability modeling to assess commercial feasibility early in development
- Rapid pilot testing and iterative optimization to align product performance with market requirements
- Production of protein ingredients that substitute animal‑derived or synthetic components in aquaculture feed, sports nutrition, cosmetics, women's health, and infant nutrition applications